Gilenya - direct healthcare professional communication (DHPC)

Fingolimod

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Gilenya (fingolimod): Updated recommendations to minimise the risk of drug-induced liver injury (DILI)

Dissemination date: 10/11/2020

Key facts

• Medicine name:
  Gilenya
• Active substance:
  Fingolimod
• Therapeutic area (MeSH):
  Multiple Sclerosis
• Procedure number:
  EMEA/H/C/PSUSA/00001393/202002
• Regulatory outcome:
  Variation
• DHPC type:
  Periodic safety update report
• Human ATC codes:
  L04AA27
• Dissemination date:
  10/11/2020